- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 26.41M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 27.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 32.6M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $185.1M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $176.2M |
| Capex | Q1 2026 · Mar 31, 2026 | $3.8M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $299.3M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $208.9M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.92B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.69B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $376.1M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $586M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.09B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.24B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $5.15B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.79B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.4B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.21B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.84 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.20 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $4.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.48 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $107.4M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $94.7M |
| Net Income | Q1 2026 · Mar 31, 2026 | $110.4M |
| Net Income | Q1 2026 · Mar 31, 2025 | $72.4M |
| Revenue | Q1 2026 · Mar 31, 2026 | $544.9M |
| Revenue | Q1 2026 · Mar 31, 2025 | $496.6M |